Journal of Translational Medicine · 2024 · 11 citations · 48 references
Life SciencesCell BiologyMolecular BiologyCell SignalingGene ExpressionSignal TransductionFibrosisJoint DiseaseJoint PathologyOsteoarthritisFibroblast-to-myofibroblast TransitionFibrosis InhibitionFibrotic ChangeKnee SynovitisSynovial Fibroblasts
BACKGROUND: Synovial fibrosis is a common complication of knee osteoarthritis (KOA), a pathological process characterized by myofibroblast activation and excessive extracellular matrix (ECM) deposition. Fibroblast-like synoviocytes (FLSs) are implicated in KOA pathogenesis, contributing to synovial fibrosis through diverse mechanisms. Nuclear protein 1 (NUPR1) is a recently identified transcription factor with crucial roles in various fibrotic diseases. However, its molecular determinants in KOA synovial fibrosis remain unknown. This study aims to investigate the role of NUPR1 in KOA synovial fibrosis through in vivo and in vitro experiments. METHODS: We examined NUPR1 expression in the murine synovium and determined the impact of NUPR1 on synovial fibrosis by knockdown models in the destabilization of the medial meniscus (DMM)-induced KOA mouse model. TGF-β was employed to induce fibrotic response and myofibroblast activation in mouse FLSs, and the role and molecular mechanisms in synovial fibrosis were evaluated under conditions of NUPR1 downexpression. Additionally, the pharmacological effect of NUPR1 inhibitor in synovial fibrosis was assessed using a surgically induced mouse KOA model. RESULTS: We found that NUPR1 expression increased in the murine synovium after DMM surgical operation. The adeno-associated virus (AAV)-NUPR1 shRNA promoted NUPR1 deficiency, attenuating synovial fibrosis, inhibiting synovial hyperplasia, and significantly reducing the expression of pro-fibrotic molecules. Moreover, the lentivirus-mediated NUPR1 deficiency alleviated synoviocyte proliferation and inhibited fibroblast to myofibroblast transition. It also decreased the expression of fibrosis markers α-SMA, COL1A1, CTGF, Vimentin and promoted the activation of the SMAD family member 3 (SMAD3) pathway. Importantly, trifluoperazine (TFP), a NUPR1 inhibitor, attenuated synovial fibrosis in DMM mice. CONCLUSIONS: These findings indicate that NUPR1 is an antifibrotic modulator in KOA, and its effect on anti-synovial fibrosis is partially mediated by SMAD3 signaling. This study reveals a promising target for developing novel antifibrotic treatment.
48
Osteoarthritis in 2020 and beyond: a Lancet Commission
David J. Hunter, Lyn March, Mabel Chew · The Lancet · 2020 · 894 citations
Synovitis score: discrimination between chronic low‐grade and high‐grade synovitis
Veit Krenn, Lars Morawietz, GR Burmester et al. · Histopathology · 2006 · 843 citations
Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression
Miao Yu, Yiwei Chen, Feng Xue et al. · EBioMedicine · 2022 · 470 citations · Full text
Henk M. van Beuningen, Harrie L. Glansbeek, P.M. van der Kraan et al. · Osteoarthritis and Cartilage · 2000 · 289 citations · Full text